Fiche publication
Date publication
mai 2024
Journal
Cancer immunology, immunotherapy : CII
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GHIRINGHELLI François
,
Mme TRUNTZER Caroline
,
Dr VINCENT Julie
,
Dr LIMAGNE Emeric
,
Dr THIBAUDIN Marion
Tous les auteurs :
Hampe L, Daumoine S, Limagne E, Roussot N, Borsotti F, Vincent J, Ilie S, Truntzer C, Ghiringhelli F, Thibaudin M
Lien Pubmed
Résumé
Glioblastoma (GBM) is a primary brain tumor with a dismal prognosis, often resistant to immunotherapy and associated with immune suppression. This study aimed to assess the impact of steroids and Stupp-regimen treatment on peripheral blood immune parameters in GBM patients and their association with outcomes.
Mots clés
Biomarker, Glioblastoma, Immune response, Steroid, Temozolomide
Référence
Cancer Immunol Immunother. 2024 05 16;73(7):133
